deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT05312151

The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

Sponsor: COMPASS Pathways

Conditions Post Traumatic Stress Disorder
Interventions Psilocybin
Updated 10 times since 2022 Last updated: May 30, 2025 Started: Jun 10, 2022 Primary completion: Feb 12, 2024 Completion: Feb 12, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Post Traumatic Stress Disorder and is currently completed. COMPASS Pathways leads this study, which shows 10 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2022 – ~Jun 2022 · 31 days · monthly snapshotRecruiting~Jun 2022 – ~Sep 2022 · 3 months · monthly snapshotRecruiting~Sep 2022 – ~Mar 2023 · 6 months · monthly snapshotRecruiting~Mar 2023 – ~Jul 2023 · 4 months · monthly snapshotRecruiting~Jul 2023 – ~Apr 2024 · 9 months · monthly snapshotRecruiting~Apr 2024 – ~May 2024 · 30 days · monthly snapshotActive Not Recruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotCompleted~Jul 2025 – present · 13 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Jul 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Jul 2025 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Apr 2024 — May 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

▶ Show 5 earlier versions

  1. Jul 2023 — Apr 2024 [monthly]

    Recruiting PHASE2

  2. Mar 2023 — Jul 2023 [monthly]

    Recruiting PHASE2

  3. Sep 2022 — Mar 2023 [monthly]

    Recruiting PHASE2

  4. Jun 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  5. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • COMPASS Pathways
Data source: COMPASS Pathways

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations